Centre for Health Policy, University of Melbourne, Melbourne, Victoria, Australia.
Nossal Institute for Global Health, University of Melbourne, Melbourne, Victoria, Australia.
PLoS One. 2018 Jun 18;13(6):e0198329. doi: 10.1371/journal.pone.0198329. eCollection 2018.
Despite a more proactive approach to reducing new HIV infections in infants through lifelong treatment (Option B+ policy) for infected pregnant women, prevention of mother-to-child transmission of HIV (PMTCT) has not been fully effective in Papua, Indonesia. Mother-to-child transmission (MTCT) is the second greatest risk factor for HIV infection in the community, and an elimination target of <1% MTCT has not yet been achieved. The purpose of this study was to improve understanding of the implementation of Option B+ for PMTCT in Papua through investigation of facilitators and barriers to women's uptake and adherence to antiretroviral therapy (ART) in the program. This information is vital for improving program outcomes and success of program scale up in similar settings in Papua.
In-depth interviews were conducted with 20 women and 20 PMTCT health workers at two main referral hospitals for PMTCT in Papua. Development of interview guides was informed by the socio-ecological framework. Qualitative data were managed with NVivo11 software and themes were analysed using template analysis. Factors influencing women's uptake and adherence in Option B+ for PMTCT were identified through final analysis of key themes.
Factors that motivated PMTCT uptake and adherence were good quality post-test HIV counselling, belief in the efficacy of antiretroviral (ARV) attained through personal or peer experiences, and a partner who did not prevent women from seeking PMTCT care. Key barriers for PMTCT participation included doubts about ARV efficacy, particularly for asymptomatic women, unsupportive partners who actively prevented women from seeking treatment, and women's concerns about community stigma and discrimination.
Results suggest that PMTCT program success is determined by facilitators and barriers from across the spectrum of the socio-ecological model. While roll out of Option B+ as current national policy for pregnant women in Papua has improved detection and enrolment of HIV-positive women, health facilities need to address various existing and potential issues to ensure long-term adherence of women beyond the current PMTCT program, including during pregnancy, childbirth and breastfeeding.
尽管印度尼西亚巴布亚采取了更积极的措施,通过为感染孕妇提供终身治疗(B+方案)来减少婴儿新感染艾滋病毒,但预防艾滋病毒母婴传播(PMTCT)的效果并不理想。母婴传播(MTCT)是社区中艾滋病毒感染的第二大风险因素,而<1%的母婴传播消除目标尚未实现。本研究旨在通过调查妇女对该方案中抗逆转录病毒治疗(ART)的接受程度和坚持程度的促进因素和障碍,来了解巴布亚实施 B+方案进行 PMTCT 的情况。这些信息对于改善方案结果以及在巴布亚类似环境中扩大方案规模的成功至关重要。
在巴布亚的两家主要 PMTCT 转诊医院,对 20 名妇女和 20 名 PMTCT 卫生工作者进行了深入访谈。访谈指南的制定参考了社会生态学框架。使用 NVivo11 软件管理定性数据,并使用模板分析对主题进行分析。通过对关键主题的最终分析,确定了影响 B+方案中妇女接受和坚持 PMTCT 的因素。
促使 PMTCT 接受和坚持的因素包括:良好的艾滋病毒检测后咨询质量、通过个人或同伴经验对抗逆转录病毒(ARV)疗效的信任、以及不阻止妇女寻求 PMTCT 护理的伴侣。PMTCT 参与的主要障碍包括对 ARV 疗效的怀疑,特别是对无症状妇女;不支持妇女寻求治疗的伴侣;以及妇女对社区耻辱和歧视的担忧。
结果表明,PMTCT 方案的成功取决于社会生态学模型各个层面的促进因素和障碍。虽然巴布亚现行国家政策将 B+方案推广给孕妇,提高了艾滋病毒阳性妇女的发现和登记率,但卫生机构需要解决各种现有和潜在的问题,以确保妇女在当前 PMTCT 方案之外,包括在怀孕期间、分娩和母乳喂养期间,长期坚持下去。